Pfizer pledges to let other companies make their Covid19 pill news in Hindi


World Desk, Amar Ujala, London

Published by: Gaurav pandey
Updated Tuesday, November 16, 2021 11:00 pm IST

listen to the news

Pharmaceutical Pfizer has partnered with a group backed by the United Nations. This agreement has been made to allow the company to manufacture its own experimental Kovid-19 drug for other companies. This step by Pfizer is believed to be able to treat more than half of the world’s population.

In a statement issued on Tuesday in this regard, Pfizer said that we would grant a license to the Geneva-based ‘Drug Patent Fund’ for the antiviral drug, allowing generic drug manufacturers to produce it. With this, this drug will be available in 95 countries around the world. 52 percent of the world’s population lives in these countries.

However, this agreement does not include some large countries, which were badly affected by the corona virus epidemic. For example, a Brazilian pharmaceutical company can obtain a license to manufacture it for export to other countries. But it cannot be manufactured generically for use in Brazil.

Health officials say that reaching this agreement before this drug is allowed anywhere could be helpful in ending the epidemic quickly. Esteban Baron, Policy Chair of the Drug Patent Fund, said it is very important that we can provide this drug to more than four billion people.

Pharmaceutical Pfizer has partnered with a group backed by the United Nations. This agreement has been made to allow the company to manufacture its own experimental Kovid-19 drug for other companies. This step by Pfizer is believed to be able to treat more than half of the world’s population.

In a statement issued on Tuesday in this regard, Pfizer said that we would grant a license to the Geneva-based ‘Drug Patent Fund’ for the antiviral drug, allowing generic drug manufacturers to produce it. With this, this drug will be available in 95 countries around the world. 52 percent of the world’s population lives in these countries.

However, this agreement does not include some large countries, which were badly affected by the corona virus epidemic. For example, a Brazilian pharmaceutical company can obtain a license to manufacture it for export to other countries. But it cannot be manufactured generically for use in Brazil.

Health officials say that reaching this agreement before this drug is allowed anywhere could be helpful in ending the epidemic quickly. Esteban Baron, Policy Chair of the Drug Patent Fund, said it is very important that we can provide this drug to more than four billion people.


www.amarujala.com

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *